• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up0.25% Nasdaq Up0.65%

    Perrigo Company plc (PRGO)

    -NYSE
    96.61 Up 0.41(0.43%) May 27, 4:02PM EDT
    |After Hours : 96.76 Up 0.15 (0.16%) May 27, 6:27PM EDT
    ProfileGet Profile for:
    Perrigo Company plc
    Treasury Building
    Lower Grand Canal Street
    Dublin, 2
    Ireland - Map
    Phone: 353 1 709 4000
    Website: http://www.perrigo.com

    Details 
    Index Membership:N/A
    Sector:Healthcare
    Industry:Drug Related Products
    Full Time Employees:13,300

    Business Summary 

    Perrigo Company plc, together with its subsidiaries, develops, manufactures, markets, and distributes over-the-counter (OTC) consumer goods and pharmaceutical products worldwide. The company operates through Consumer Healthcare (CHC), Branded Consumer Healthcare (BCH), Prescription Pharmaceuticals (Rx), Specialty Sciences, and Other segments. The CHC segment offers OTC products in various categories, including analgesics, cough/cold/allergy/sinus, gastrointestinal, infant nutritional, smoking cessation, animal health, feminine hygiene, diabetes and dermatological care, diagnostic, scar management, and other healthcare products, as well as vitamins, minerals, and dietary supplements (VMS); and contract manufacturing services. It serves retail drug, supermarket, mass merchandise chains, and wholesalers through sales force and industry brokers. The BCH segment provides branded OTC products in the natural health and VMS; cough, cold, flu, and allergy; personal care and derma-therapeutics; lifestyle; pain relief, nasal decongestants, and cold sore management; and anti-parasite areas, as well as offers generic pharmaceutical products. It serves pharmacies, drug, and grocery stores through pharmacy sales force, as well as a network of pharmacists. The Rx segment offers generic and specialty pharmaceutical prescription drugs in various dosage forms, such as creams, ointments, lotions, gels, shampoos, foams, suppositories, sprays, liquids, suspensions, solutions, powders, controlled substances, injectables, hormones, women's health products, oral solid dosage forms, and oral liquid formulations; and ORx products. It serves wholesalers; retail drug, supermarket, and mass merchandise chains; hospitals; and pharmacies. The Specialty Sciences segment offers Tysabri to treat multiple sclerosis. The Other segment offers active pharmaceutical ingredients used by generic and branded pharmaceutical companies. The company was founded in 1887 and is headquartered in Dublin, Ireland.

    Key Statistics


    Company Websites 
    Home Page
    Search Yahoo! for:
    More on Perrigo Company plc

    Corporate Governance 
    Perrigo Company plc’s ISS Governance QuickScore as of May 1, 2016 is 9. The pillar scores are Audit: 1; Board: 7; Shareholder Rights: 2; Compensation: 10.
    Brought to you by Institutional Shareholder Services (ISS)

    Key Executives 
     PayExercised
    Mr. John T. Hendrickson , 53
    Chief Exec. Officer
    641.00K281.00K
    Ms. Judy L. Brown , 47
    Chief Financial Officer, Principal Accounting Officer and Exec. VP
    1.00M0.00
    Mr. Todd W. Kingma , 56
    Exec. VP, Gen. Counsel and Sec.
    914.00K0.00
    Mr. Sharon Kochan , 48
    Exec. VP and Gen. Mang. of International
    857.00K352.00K
    Mr. Jeffrey R. Needham , 60
    Exec. VP and Gen. Mang. of Consumer Healthcare
    407.00K0.00
    Amounts are as of Dec 31, 2015 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in USD.
    View Insiders